Patents/Assignees

IMMUNE TARGETING Inc.

2 patents in portfolio

US12441781utility2025
Interleukin 15 Fusion Proteins, and Compositions and Therapeutic Methods Thereof
0 cites
US11597753utility2023
Activatable IL2 Composition and Methods of Use
0 cites